Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: SDS-PAGE
製品名Recombinant Human PAI1 + PLAU protein
精製度> 95 % SDS-PAGE.
Human PAI1 stable mutant is reacted with an excess of Human PLAU at physiological pH. Excess PLAU is removed from the resulting 1:1 molar complex by immobilized benzamidine resin.
タンパク質長Full length protein
Our Abpromise guarantee covers the use of ab92553 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Concentration information loading...
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
Constituents: 2.38% HEPES, 0.58% Sodium chloride
- Endothelial plasminogen activator inhibitor
関連性PAI1 acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis. PLAU specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab92553 は 1 報の論文で使用されています。
- Gao LM et al. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter. J Cell Mol Med 23:6411-6428 (2019). PubMed: 31317666